» Articles » PMID: 29483901

Rewriting the Metabolic Blueprint: Advances in Pathway Diversification in Microorganisms

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2018 Feb 28
PMID 29483901
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Living organisms have evolved over millions of years to fine tune their metabolism to create efficient pathways for producing metabolites necessary for their survival. Advancement in the field of synthetic biology has enabled the exploitation of these metabolic pathways for the production of desired compounds by creating microbial cell factories through metabolic engineering, thus providing sustainable routes to obtain value-added chemicals. Following the past success in metabolic engineering, there is increasing interest in diversifying natural metabolic pathways to construct non-natural biosynthesis routes, thereby creating possibilities for producing novel valuable compounds that are non-natural or without elucidated biosynthesis pathways. Thus, the range of chemicals that can be produced by biological systems can be expanded to meet the demands of industries for compounds such as plastic precursors and new antibiotics, most of which can only be obtained through chemical synthesis currently. Herein, we review and discuss novel strategies that have been developed to rewrite natural metabolic blueprints in a bid to broaden the chemical repertoire achievable in microorganisms. This review aims to provide insights on recent approaches taken to open new avenues for achieving biochemical production that are beyond currently available inventions.

Citing Articles

Engineered microbial consortia for next-generation feedstocks.

Hossain G, Liang Y, Foo J, Chang M Biotechnol Notes. 2024; 5:23-26.

PMID: 39416694 PMC: 11446362. DOI: 10.1016/j.biotno.2024.01.002.


Mechanistic Aspects for the Modulation of Enzyme Reactions on the DNA Scaffold.

Lin P, Yang H, Nakata E, Morii T Molecules. 2022; 27(19).

PMID: 36234845 PMC: 9572797. DOI: 10.3390/molecules27196309.


Metabolic engineering of a methyltransferase for production of drug precursors demecycline and demeclocycline in .

Yang W, Kong L, Wang Q, Deng Z, You D Synth Syst Biotechnol. 2020; 5(3):121-130.

PMID: 32637665 PMC: 7320239. DOI: 10.1016/j.synbio.2020.06.001.


Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional microorganisms.

Calero P, Nikel P Microb Biotechnol. 2018; 12(1):98-124.

PMID: 29926529 PMC: 6302729. DOI: 10.1111/1751-7915.13292.

References
1.
Wallace S, Balskus E . Opportunities for merging chemical and biological synthesis. Curr Opin Biotechnol. 2014; 30:1-8. PMC: 4199929. DOI: 10.1016/j.copbio.2014.03.006. View

2.
Proschel M, Detsch R, Boccaccini A, Sonnewald U . Engineering of Metabolic Pathways by Artificial Enzyme Channels. Front Bioeng Biotechnol. 2015; 3:168. PMC: 4617052. DOI: 10.3389/fbioe.2015.00168. View

3.
Walther T, Topham C, Irague R, Auriol C, Baylac A, Cordier H . Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor 2,4-dihydroxybutyric acid. Nat Commun. 2017; 8:15828. PMC: 5481828. DOI: 10.1038/ncomms15828. View

4.
Kan S, Huang X, Gumulya Y, Chen K, Arnold F . Genetically programmed chiral organoborane synthesis. Nature. 2017; 552(7683):132-136. PMC: 5819735. DOI: 10.1038/nature24996. View

5.
Yao Y, Wang C, Qiao J, Zhao G . Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway. Metab Eng. 2013; 19:79-87. DOI: 10.1016/j.ymben.2013.06.001. View